Evidence map›Paper›PMID 41057964›Full record

ArticleMicrobiome2025

Members of Lachnospiraceae produce valerate and caproate in response to short-chain fatty acids.

Bradley G Fitzgerald, Manitabhai Govind, Isaac J Firth, Loudon Herold, Julia Froment, Sarah J Vancuren, Emma Allen-Vercoe, Matthew S Kimber, Matthew T Sorbara

Abstract read
In one paragraph

Article in Microbiome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. The Role ofInternational journal of molecular sciences · 2026
    Review
  6. Article
  7. Article
  8. Phytosynbiotic Containing Double-Layer MicroencapsulatedAnimals : an open access journal from MDPI · 2026
    Article
  9. Article
  10. Article
  11. Frontiers in cellular and infection microbiology · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bradley G FitzgeraldDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada.
Manitabhai GovindDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada.
Isaac J FirthDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada.
Loudon HeroldDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada.
Julia FromentDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada.
Sarah J VancurenDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada.
Emma Allen-VercoeDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada.
Matthew S KimberDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada.
Matthew T SorbaraDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada. msorbara@uoguelph.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe human gut microbiota ferments carbohydrates to produce metabolites that mediate beneficial community functions. While the production of the short-chain fatty acids (SCFAs) acetate, propionate, and butyrate is well characterized, how valerate and caproate are produced has remained enigmatic.

resultsHere, we characterize the production of valerate and caproate by the gut microbiota. In a continuous culture model of a defined gut bacterial community, we observed that valerate took longer to reach physiological levels than acetate, propionate, or butyrate and correlated with Lachnospiraceae. This led us to test valerate and caproate production by members of Lachnospiraceae. While tested Lachnospiraceae isolates produced low levels of valerate and caproate at baseline, physiological concentrations of SCFAs activated valerate and caproate production in a species-specific manner. Furthermore, providing isotopically labelled SCFAs revealed that isolates of Anaerostipes hadrus and Coprococcus comes, which are members of Lachnospiraceae, directly incorporate exogenous acetate, propionate, and butyrate into valerate and caproate in a manner consistent with the reverse β-oxidation pathway. Therefore, we examined this pathway in Lachnospiraceae and found that Lachnospiraceae spp. encode different copy numbers and variants of the enzyme acetyl-CoA acetyltransferase (ThlA). ThlA performs the first step in reverse β-oxidation by condensing acyl-CoA molecules. We demonstrate that tested Lachnospiraceae ThlA protein variants consume propionyl-CoA and acetyl-CoA substrates consistent with valerate production. Coprococcus comes, the only tested species to produce caproate, encodes a second ThlA protein with increased activity on butyryl-CoA. In human fecal samples, multiple genera of Lachnospiraceae correlate with butyrate, while Coprococcus also correlates with caproate levels.

conclusionsThese findings reveal a role of certain members of the Lachnospiraceae as prominent producers of valerate and caproate within human microbiomes through the reverse β-oxidation pathway.

Indexed as

CaproatesEubacterialesFatty Acids, VolatileGastrointestinal MicrobiomeValeratesButyratesFermentationHumansPropionatesButyratesCaproatesFatty Acids, VolatilePropionatesValerates

Identifiers

PMID41057964
PMCPMC12505567

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.